Frequency Electronics, Inc. — Form 10-Q Summary
Reporting period: Three and six months ended October 31, 2023 (fiscal second quarter and first half of fiscal 2024). Comparisons are with the periods ended October 31, 2022. Unaudited consolidated results; dollar amounts below are in millions unless noted.
Business context and key financial results
The company develops precision time and frequency-control products and systems for satellite communications, government and defense, telecommunications, and other commercial markets. Its reportable segments are FEI-NY and FEI-Zyfer.
| Metric | Three months ended Oct. 31, 2023 | Six months ended Oct. 31, 2023 | Comparable 2022 periods |
|---|---|---|---|
| Revenue | $13.575 million | $25.984 million | $8.949 million; $17.153 million |
| Gross profit / margin rate | $4.330 million / 31.9% | $9.198 million / 35.4% | $0.350 million / 3.9%; $0.345 million / 2.0% |
| Operating income (loss) | $0.938 million | $2.998 million | $(2.283) million; $(5.390) million |
| Net income (loss) | $0.797 million | $2.839 million | $(2.314) million; $(5.431) million |
| Diluted EPS | $0.08 | $0.30 | $(0.25); $(0.58) |
Revenue increased 51.7% for the quarter and 51.5% for the six-month period versus 2022. FEI-NY revenue was $9.271 million for the quarter and $18.762 million for six months; FEI-Zyfer revenue was $4.756 million and $8.023 million, respectively. Government non-space/DoD customers represented about 60% of quarterly and 58% of first-half revenue; satellite programs represented about 34% and 37%, respectively.
Cash flow, liquidity, and obligations
- Operating cash flow was negative $2.981 million for the first six months, compared with negative $0.466 million in 2022, despite the return to profitability. Management attributed the cash use mainly to higher inventory and lower contract liabilities.
- Investing cash use was $0.360 million, primarily capital expenditures; there were no financing cash flows. Cash declined to $8.708 million at October 31, 2023 from $12.049 million at April 30, 2023.
- Working capital was approximately $24.7 million and the current ratio was 2.0:1, versus $21.0 million and 1.8:1 at April 30, 2023. The company reported no borrowings and no available credit-facility capacity.
- Operating lease liabilities totaled $6.895 million, of which $1.769 million was current. The company had no material off-balance-sheet arrangements.
- Funded backlog was approximately $50 million, down from $57 million at April 30, 2023; about 75% was expected to be realized within twelve months. Backlog excludes unauthorized or unfunded amounts and is not necessarily indicative of future revenue or profit.
Material changes, outlook, and risks
- Management attributed higher revenue to contract awards, resolution of prior-year technical problems, and operational improvements. Gross margin improved as affected programs advanced and ran more efficiently; management also cited cost-cutting measures initiated in fiscal 2023.
- Quarterly SG&A rose 25.5% to $2.552 million, mainly from professional fees and payroll-related costs. Quarterly R&D rose 40.2% to $0.840 million; first-half R&D fell 21.2% to $1.347 million, reflecting employee shifts between production and development. Management expects to continue investing in R&D.
- Contract-loss provisions recorded in cost of revenue were approximately $1.4 million for the quarter and $1.5 million for six months. Revenue and inventory accounting depend on estimates, including contract costs to complete, inventory realizability, and product values; changes in estimates can materially affect results.
- Management said liquidity should cover short-term operating and investment needs through at least December 15, 2024, and longer-term needs for the foreseeable future. It expects internally generated cash to support planned R&D; acquisitions may involve internal or external funding. No specific revenue or earnings guidance was provided.
- The company maintains a full valuation allowance against deferred tax assets; its estimated fiscal 2024 annual effective tax rate was 0%. The 4.6% investment in Russian company Morion was fully impaired in fiscal 2022; its future status remains uncertain given the Russia-Ukraine conflict and sanctions, and future transactions or dividends are considered remote.
- Risks cited include reliance on significant customers, including the U.S. government; competition and technology changes; raw-material, manufacturing, and transportation costs; third-party suppliers; capital availability; and litigation or arbitration. The filing reported no material changes to the risk factors in the prior Form 10-K.
Important facts for investors to verify
- Whether improved program execution and gross margins persist, and how much results depend on contract-cost estimates and loss provisions.
- Whether backlog converts into funded orders, revenue, and cash on the expected timetable, including the concentration in government and satellite customers.
- Whether inventory growth and contract-asset increases translate into billing and collections; operating cash flow remained negative in the first half.
- Whether cash and working capital remain adequate without a borrowing facility, particularly alongside planned R&D and potential acquisitions.
- How sanctions and the impairment affect any remaining exposure or business relationship with Morion.